Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 6
Merck Recalls Vioxx Worldwide Over Safety Concerns
N.J Court Denies Merck Motion to Dismiss Out-Of-State Plaintiffs
N.Y. Man Blames Merck's Vioxx for Heart Attack
Presiding Judge Names Liaison Counsel in 156 N.J. Vioxx Cases
Arthritis Drugs - Issue: 5
Merck Disputes Conclusions of Vioxx Study Presented at Bordeaux Conference
5th Circuit Orders Lower Court to Reconsider Statute of Limitations Dismissal
Arthritis Drugs - Issue: 4
Ala. Woman Dismisses with Prejudice Claims against Vioxx Maker
Learned Intermediary Doctrine Bars Plaintiffs' Breach of Warranty, Consumer Fraud Claims
